 |
 |
Introduction
Joymed Technology, founded in 2014, is a leading medical device CDMO (Contract Design and Manufacturing Organization) serving global medical device manufacturers. We distinguish ourselves by not having our own product branding and providing strong protection for customer’s IP. Our comprehensive services span from design and development to regulatory compliance and contract manufacturing. Our global footprint includes: Shanghai (Head Office) for product development and engineering; Suzhou and Changsha for capital equipment and disposables CDMO; Changzhou specializing in precision injection molding and tube extrusion; and Singapore for high-level assembly and testing. Joymed is ISO 13485 certified across multiple locations. Our team comprises over 300 personnel with extensive medical industrial experience, including key members with over 15 years of experience in global companies. We offer one-stop CDMO services for Class I, II, and III medical devices, emphasizing quality, efficiency, and a collaborative approach.
CSSD/IBCC Support
As Joymed Technology expanded its global footprint, Singapore emerged as a crucial hub for our regional operations. CSSD played a pivotal role in facilitating our smooth market entry and business growth by providing extensive support across multiple dimensions, from securing operational space to fostering strategic connections and engagement with key stakeholders. One of CSSD’s key contributions was assisting us in acquiring our current 3,000-squarefoot office and assembly/testing facility in 2023. This space serves as an essential base for high-level assembly and testing, reinforcing our commitment to delivering top-tier CDMO services for global medical device manufacturers. Beyond infrastructure support, CSSD actively introduced us to potential clients within the medtech sector, helping us establish valuable business relationships. They also played a significant role in organizing industry networking events, allowing us to connect with industry leaders, exchange insights, and explore collaboration opportunities. Furthermore, CSSD facilitated our engagement with critical government bodies such as the Singapore Economic Development Board (EDB), Enterprise Singapore (ESG), and A*STAR. These connections provided us with access to government-backed initiatives,funding opportunities, and research collaborations that aligned with our strategic objectives in Singapore. In addition to business and regulatory support, CSSD fostered a strong sense of community for Joymed. Through their frequent invitations to networking events, industry gatherings, and social activities, they enabled us to build meaningful relationships within the medtech ecosystem, further integrating us into Singapore’s business landscape. The combination of CSSD’s proactive assistance and Singapore’s thriving medtech infrastructure has laid a solid foundation for Joymed’s continued success in the region. Their ongoing support remains instrumental in helping us navigate new opportunities and strengthen our presence in this dynamic market.
 |
 |
Conclusion
Singapore’s well-established medtech ecosystem, combined with CSSD’s dedicated support, has been instrumental in Joymed’s successful expansion. The seamless business environment, coupled with access to a strong network of multinational medical device companies, a robust supply chain, and a highly skilled talent pool, has provided us with the confidence and capability to scale our operations effectively. By setting up in Singapore, we have strengthened our position as a trusted CDMO partner, delivering high-quality and IP-secure solutions to global medical device manufacturers. As we continue to innovate and expand, CSSD remains a valuable partner, enabling us to drive technological advancements and contribute to the evolving global medtech landscape.